Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications

Yazar: Juan, Oscar, Popat, Sanjay
Yayımlandı Ther Adv Med Oncol (2017)

Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC

Yazar: McDonald, Fiona, Popat, Sanjay
Baskı/Yayın Bilgisi 2014

Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer

Yazar: Yap, Timothy A, Popat, Sanjay
Baskı/Yayın Bilgisi 2014

Polymorphic sequence variants in medicine: a challenge and an opportunity

Yazar: Hodgson, Shirley V, Popat, Sanjay
Yayımlandı Clin Med (Lond) (2003)

Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance

Yazar: Popat, Sanjay, Wort, Richard, Houlston, Richard S
Baskı/Yayın Bilgisi 2006

Highlights in lung cancer in 2019

Yazar: Lim, Kok Haw Jonathan, Popat, Sanjay
Yayımlandı ESMO Open (2020)

Resolution of severe hyponatraemia is associated with improved survival in patients with cancer

Yazar: Balachandran, Kirsty, Okines, Alicia, Gunapala, Ranga, Morganstein, Daniel, Popat, Sanjay
Yayımlandı BMC Cancer (2015)

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

Yazar: Hubner, Richard A., Riley, Richard D., Billingham, Lucinda J., Popat, Sanjay
Baskı/Yayın Bilgisi 2011

Durable response of multiple myeloma and non‐small cell lung cancer with simultaneous, biologically targeted treatment

Yazar: Kaiser, Martin F., Croft, James, Shah, Paras, Yousaf, Nadia, Popat, Sanjay
Yayımlandı Br J Haematol (2020)

Problems of variable biomarker evaluation in stratified medicine research—A case study of ERCC1 in non-small-cell lung cancer

Yazar: Malottki, Kinga, Popat, Sanjay, Deeks, Jonathan J., Riley, Richard D., Nicholson, Andrew G., Billingham, Lucinda
Yayımlandı Lung Cancer (2016)

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

Yazar: Gennatas, Spyridon, Stanway, Susana J, Thomas, Robert, Min, Toon, Shah, Riyaz, O’Brien, Mary ER, Popat, Sanjay
Baskı/Yayın Bilgisi 2013

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach

Yazar: Popat, Sanjay, Navani, Neal, Kerr, Keith M., Smit, Egbert F., Batchelor, Timothy J.P., Van Schil, Paul, Senan, Suresh, McDonald, Fiona
Yayımlandı Oncologist (2020)

Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond

Yazar: Joshi, Kroopa, Muhith, Abdul, Obeid, Mariam, Milner-Watts, Charlotte, Yousaf, Nadia, Popat, Sanjay, Davidson, Michael, Bhosle, Jaishree, O’Brien, Mary, Minchom, Anna
Yayımlandı Lung Cancer (2021)

A Comparison of Immunohistochemical Assays and FISH in Detecting the ALK Translocation in Diagnostic Histological and Cytological Lung Tumor Material

Yazar: Le Quesne, John, Maurya, Manisha, Yancheva, Slaveya G., O’Brien, Mary, Popat, Sanjay, Wotherspoon, Andrew C., de Castro, David Gonzalez, Nicholson, Andrew G.
Baskı/Yayın Bilgisi 2014

A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in pati...

Yazar: Minchom, Anna, Mak, Daisy, Gunapala, Ranga, Walder, David, Kumar, Rajiv, Yousaf, Nadia, Hodgkiss, Andrew, Bhosle, Jaishree, Popat, Sanjay, O’Brien, Mary E. R.
Yayımlandı PLoS One (2019)

A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice

Yazar: Linch, Mark, Gennatas, Spyridon, Kazikin, Stanislav, Iqbal, Jhangir, Gunapala, Ranga, Priest, Kathryn, Severn, Joanne, Norton, Alison, Ayite, Bee, Bhosle, Jaishree, O’Brien, Mary, Popat, Sanjay
Baskı/Yayın Bilgisi 2014

Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience

Yazar: Cui, Wanyuan, Yousaf, Nadia, Bhosle, Jaishree, Minchom, Anna, Nicholson, Andrew G., Ahmed, Merina, McDonald, Fiona, Locke, Imogen, Lee, Richard, O'Brien, Mary, Popat, Sanjay
Yayımlandı Cancer Treat Res Commun (2020)

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

Yazar: Minchom, Anna, Thavasu, Parames, Ahmad, Zai, Stewart, Adam, Georgiou, Alexandros, O’Brien, Mary E. R., Popat, Sanjay, Bhosle, Jaishree, Yap, Timothy A., de Bono, Johann, Banerji, Udai
Yayımlandı PLoS One (2017)

Extraskeletal Myxoid Chondrosarcoma: A Retrospective Review From 2 Referral Centers Emphasizing Long-term Outcomes With Surgery and Chemotherapy

Yazar: Drilon, Alex D., Popat, Sanjay, Bhuchar, Gauri, D’Adamo, David R., Keohan, Mary Louise, Fisher, Cyril, Antonescu, Cristina R., Singer, Samuel, Brennan, Murray F., Judson, Ian, Maki, Robert G.
Baskı/Yayın Bilgisi 2008

Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice

Yazar: Abdelraouf, Fatma, Sharp, Adam, Maurya, Manisha, Mair, Debbie, Wotherspoon, Andrew, Leary, Alex, Gonzalez de Castro, David, Bhosle, Jaishree, Nassef, Ayatallah, Gaafar, Taghrid, Popat, Sanjay, Yap, Timothy A., O’Brien, Mary
Yayımlandı BMC Res Notes (2015)